| Dr Scott Wood, MD | |
|
221 W Colorado Blvd, Ste 525, Dallas, TX 75208-2312 | |
| (214) 960-5681 | |
| (214) 947-2727 |
| Full Name | Dr Scott Wood |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 28 Years |
| Location | 221 W Colorado Blvd, Dallas, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265516934 | NPI | - | NPPES |
| 0061SG | Other | TX | BC/BS GROUP |
| 205693901 | Medicaid | TX | |
| 0A3635 | Other | UT | MEDICARE GROUP |
| 8F21072 | Other | TX | MEDICARE INDIVIDUAL NUMBER |
| 8BZ422 | Other | TX | BC/BS INDIVIDUAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | L4814 (Texas) | Secondary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | L4814 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Dallas Medical Center | Dallas, TX | Hospital |
| Baylor Scott And White Medical Center Lake Pointe | Rowlett, TX | Hospital |
| Medical City Plano | Plano, TX | Hospital |
| Baylor Scott & White Medical Center- Waxahachie | Waxahachie, TX | Hospital |
| Entity Name | Scott Wood, M.d., P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316188980 PECOS PAC ID: 2567519010 Enrollment ID: O20090420000619 |
News Archive
"Lawyers for health insurers and the state sparred in court yesterday over regulators' rejection of 235 proposed rate increases, and a judge said he would decide by Monday whether the companies will be allowed to charge the higher prices." The insurers are arguing that the state's insurance commissioner overstepped his authority in rejecting the 235 of 274 requests to increase premiums (Weisman, 4/9).
Quebec patients with serious blood cancers (intermediate-2 and high-risk myelodysplastic syndrome and acute myeloid leukemia) now have publicly funded access to a new innovative therapy, VIDAZA® (azacitidine). Following a priority review and subsequent positive recommendation from the Conseil du medicament, patients now have the potential to significantly extend survival.
Microgravity in space perturbs human physiology and is detrimental for astronaut health, a fact first realized during early Apollo missions when astronauts experienced inner ear disturbances, heart arrhythmia, low blood pressure, dehydration, and loss of calcium from their bones after their mission.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced the start of clinical testing with SAR566658. Eight compounds are now in the clinic through ImmunoGen's product programs and those of its partners, consistent with Company expectations of as many as 12 such compounds being in the clinic by late 2011 and marked, sustained pipeline growth thereafter.
NPR reports on Judge Edward Korman's response to the Obama administration's Plan B proposal while CNN Money explores how the "conscience clause" creates challenges for drugstores as they sell the morning-after pill over the counter.
› Verified 8 days ago
| Entity Name | Dallas Pulmonary & Critical Care, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235402728 PECOS PAC ID: 2163679200 Enrollment ID: O20120824000752 |
News Archive
"Lawyers for health insurers and the state sparred in court yesterday over regulators' rejection of 235 proposed rate increases, and a judge said he would decide by Monday whether the companies will be allowed to charge the higher prices." The insurers are arguing that the state's insurance commissioner overstepped his authority in rejecting the 235 of 274 requests to increase premiums (Weisman, 4/9).
Quebec patients with serious blood cancers (intermediate-2 and high-risk myelodysplastic syndrome and acute myeloid leukemia) now have publicly funded access to a new innovative therapy, VIDAZA® (azacitidine). Following a priority review and subsequent positive recommendation from the Conseil du medicament, patients now have the potential to significantly extend survival.
Microgravity in space perturbs human physiology and is detrimental for astronaut health, a fact first realized during early Apollo missions when astronauts experienced inner ear disturbances, heart arrhythmia, low blood pressure, dehydration, and loss of calcium from their bones after their mission.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced the start of clinical testing with SAR566658. Eight compounds are now in the clinic through ImmunoGen's product programs and those of its partners, consistent with Company expectations of as many as 12 such compounds being in the clinic by late 2011 and marked, sustained pipeline growth thereafter.
NPR reports on Judge Edward Korman's response to the Obama administration's Plan B proposal while CNN Money explores how the "conscience clause" creates challenges for drugstores as they sell the morning-after pill over the counter.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott Wood, MD 221 W Colorado Blvd, Ste 525, Dallas, TX 75208-2312 Ph: (214) 960-5681 | Dr Scott Wood, MD 221 W Colorado Blvd, Ste 525, Dallas, TX 75208-2312 Ph: (214) 960-5681 |
News Archive
"Lawyers for health insurers and the state sparred in court yesterday over regulators' rejection of 235 proposed rate increases, and a judge said he would decide by Monday whether the companies will be allowed to charge the higher prices." The insurers are arguing that the state's insurance commissioner overstepped his authority in rejecting the 235 of 274 requests to increase premiums (Weisman, 4/9).
Quebec patients with serious blood cancers (intermediate-2 and high-risk myelodysplastic syndrome and acute myeloid leukemia) now have publicly funded access to a new innovative therapy, VIDAZA® (azacitidine). Following a priority review and subsequent positive recommendation from the Conseil du medicament, patients now have the potential to significantly extend survival.
Microgravity in space perturbs human physiology and is detrimental for astronaut health, a fact first realized during early Apollo missions when astronauts experienced inner ear disturbances, heart arrhythmia, low blood pressure, dehydration, and loss of calcium from their bones after their mission.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced the start of clinical testing with SAR566658. Eight compounds are now in the clinic through ImmunoGen's product programs and those of its partners, consistent with Company expectations of as many as 12 such compounds being in the clinic by late 2011 and marked, sustained pipeline growth thereafter.
NPR reports on Judge Edward Korman's response to the Obama administration's Plan B proposal while CNN Money explores how the "conscience clause" creates challenges for drugstores as they sell the morning-after pill over the counter.
› Verified 8 days ago
Uma B.r.k Pakkivenkata, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 215, Dallas, TX 75231 Phone: 214-396-4950 Fax: 877-423-5360 | |
Dr. Ariel Marcelo Modrykamien, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3600 Gaston Ave, Wadley Tower, Suite 960, Dallas, TX 75246 Phone: 402-972-6078 | |
Benjamin Seth Martinez, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3111 Fax: 214-648-5461 | |
Vijaya Mummadi, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 225, Dallas, TX 75231 Phone: 469-646-8880 Fax: 469-646-8884 | |
Dr. Ting-yi Chen, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2800 Fax: 214-645-2808 | |
William Cook Langmade, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 1441 N Beckley Ave, Dallas, TX 75203 Phone: 214-947-2306 | |
Dr. Janame J Kottey, MBBS Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 13154 Coit Rd Ste 100, Dallas, TX 75240 Phone: 214-358-2300 Fax: 214-579-6989 |